Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

NCT04644120 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

CoronaVirus Disease-2019 (COVID-19)

Interventions

DRUG: ABBV-47D11
DRUG: Placebo for ABBV-47D11
DRUG: ABBV-2B04
DRUG: Placebo for ABBV-2B04

Sponsor

AbbVie